Showing results (151-160 of 160) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Plos One|February 9, 2018
A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in KoreaDong Wook Shin, Sohyun Chun, Young Il Kim, et al.Thoracic Cancer|January 3, 2024
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South KoreaDa Som Jeon, Cheol-Kyu Park, Seung Joon Kim, et al.Analytical Chemistry|June 10, 2024
U-Shape Pillar Strip for 3D Cell-Lumped Organoid Model (3D-COM) Mimicking Lung Cancer Hypoxia Conditions in High-Throughput Screening (HTS)Sang-Yun Lee, Eunyoung Lee, Jeong Uk Lim, et al.Cancer Medicine|August 20, 2024
Epigenome-wide association study of prostate cancer in African American men identified differentially methylated genesAnders Berglund, Kosj Yamoah, Steven A Eschrich, et al.Nature Aging|March 14, 2025
Interleukin-12 signaling drives Alzheimer's disease pathology through disrupting neuronal and oligodendrocyte homeostasisShirin Schneeberger, Seung Joon Kim, Maria N Geesdorf, et al.Journal of Experimental & Clinical Cancer Research : CR|November 23, 2023
Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)Sang-Yun Lee, Hyeong Jun Cho, Jimin Choi, et al.Cancer Research and Treatment|September 1, 2022
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung CancerJang Ho Lee, Eun Young Kim, Cheol-Kyu Park, et al.Translational Lung Cancer Research|February 9, 2026
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort studyMin Jee Kim, Junghee Jung, Wonjun Ji, et al.Antimicrobial Agents and Chemotherapy|December 6, 2021
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary TuberculosisJu Sang Kim, Yong-Hyun Kim, Sang Haak Lee, et al.NPJ Precision Oncology|May 21, 2024
Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusionSang-Hyun Lee, Kyuhwan Kim, Eunyoung Lee, et al.Pageof 16